News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

News|Articles|May 1, 2004

Follow-up: Abortionbreast cancer link disavowed

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Adherence, Specialty Pharmacies, and the Future of Precision Pediatric Care

ByAdelaide A. Hebert, MD,Autumn Atkinson, MD

February 9th 2026

Experts discuss neurodevelopmental outcomes after assisted delivery | Image Credit: giuliamuraca.com.

Experts discuss neurodevelopmental outcomes after assisted delivery

ByGiulia M. Muraca, MPH, PhD,Maya Rajasingham, BSc

February 5th 2026

Nancy Young, MD, discusses predicting language outcomes after cochlear implant | Image Credit: feinberg.northwestern.edu.

Nancy Young, MD, discusses predicting language outcomes after cochlear implant

ByNancy Young, MD

February 4th 2026

Asma Khalil, PhD, explains how prenatal paracetamol use does not increase developmental risks | Image Credit: stgeorges.nhs.uk.

Asma Khalil, PhD, explains how prenatal paracetamol use does not increase developmental risks

ByAsma Khalil, PhD

February 2nd 2026

Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy

ByAdelaide A. Hebert, MD,Autumn Atkinson, MD

February 2nd 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Trending on Contemporary Pediatrics

Which children are most at risk for food allergy? New meta-analysis offers answers

Matthew Neidell, PhD, discusses community water fluoridation and birth outcomes

Switching from dupilumab to upadacitinib improves skin clearance, itch in atopic dermatitis

Oral infigratinib linked to improved growth and proportionality in achondroplasia

Rezpegaldesleukin maintenance data show durable responses in moderate-to-severe atopic dermatitis